Clinical and Experimental Hepatology

Endoscopic ultrasound-guided interventions for biliary drainage

  1. Department of General, Gastroenterological and Oncological Surgery, Collegium Medicum Nicolaus Copernicus University in Toruń, Poland

  2. Department of Gastroenterology and Hepatology, Jagiellonian University Medical College, Cracow, Poland

  3. Department of Gastroenterology, University of Michigan-Sparrow, USA

Clin Exp HEPATOL 2026; 12, 4:

Data publikacji online: 2026/11/12
Article file
Endoscopic Kukla 00821.pdf

Introduction

Bile duct stenosis is defined as a significant impairment of bile flow from the liver due to a mechanical cause [1-6]. Clinical presentation and laboratory findings in patients with bile duct stenosis are dominated by manifestations of cholestatic jaundice [1-3]. In imaging studies, prestenotic dilatation of bile ducts due to biliary stasis upstream of the stricture is a characteristic feature [1-4].

Depending on their location along the bile outflow path, biliary strictures are classified into proximal strictures (involving intrahepatic bile ducts) and distal strictures (involving extrahepatic bile ducts) [1, 2, 4]. Another classification defines distal biliary strictures as narrowings within the distal (intrapancreatic) segment of the common bile duct [1, 2, 5, 6].

Biliary strictures can also be classified according to their etiology. A distinction is made between benign biliary strictures and malignant biliary strictures, the latter being defined as strictures caused by malignant neoplasms [3-6]. An extensive diagnostic process is required to determine the etiology of a biliary stricture so that appropriate treatment can be promptly implemented once the diagnosis is made [1, 3, 5, 6]. Most biliary strictures are malignant at the time of diagnosis (76-85% of cases) [5-8]. Accurate diagnosis in patients presenting with obstructive jaundice in the course of biliary stenosis is critical because it determines subsequent therapeutic management.

Radiological imaging studies and endoscopic examinations are of key importance in the differential diagnosis of biliary strictures [1, 6-8]. Contrast-enhanced multiphasic computed tomography (CECT) of the abdomen and abdominal magnetic resonance cholangiopancreatography (MRCP) are thought to be essential for the detection and characterization of lesions, as well as for determining local tumor stage and assessing for distant metastases in the case of malignant lesions, thereby helping determine tumor resectability [1, 2, 4, 6, 7]. Endoscopic ultrasonography (EUS) with possible biopsy and ERCP with brush cytology or biopsy should also be taken into account as part of the diagnostic process in biliary stenosis [6-8]. However, it is important to note that imaging studies should be performed before invasive procedures, such as EUS or ERCP [6-8].

The two most common causes of malignant biliary strictures include pancreatic cancer and biliary tract cancer [7, 9-11]. Less common causes of neoplastic biliary stenosis include carcinoma of the major duodenal papilla, carcinoma of the gallbladder, hepatocellular carcinoma, duodenal carcinoma, lymphoproliferative disease, or metastatic disease, i.e., including liver metastases [2, 7]. The steady increase in the incidence of pancreatic cancer [5, 10] and biliary tract cancer [5, 11, 12] observed over the past few years, makes the endoscopic management of patients with obstructive jaundice due to malignant biliary strictures a very important and ongoing clinical concern. Patients with malignant biliary stenosis usually experience a reduced quality of life due to clinical symptoms resulting from cholestasis and a poor prognosis associated with the underlying malignancy [10-12]. However, the continued development of advanced endoscopic techniques can frequently contribute to an improvement in these patients’ quality of life [13-16].

The aim of this article is to discuss the endoscopic treatment of patients with obstructive jaundice based on available literature data. It summarizes the current knowledge on the role of transpapillary and transmural approaches in biliary endotherapy, based on a literature review and the authors’ own experience. Furthermore, the article presents the possibilities of the transmural endoscopic approach to biliary drainage and new perspectives on the development of biliary endotherapy offered by therapeutic EUS.

Minimally invasive therapeutic management of biliary strictures

The mainstay of treatment of patients with malignant biliary stenosis consists in ensuring proper bile outflow [1-5, 9]. Over the past nearly 40 years, minimally invasive techniques for biliary drainage have steadily developed, including percutaneous [17-20] and endoscopic transpapillary drainage [1, 2, 21]. A well-established and widely practiced method for symptomatic treatment of patients with malignant biliary stenosis is ERCP with the placement of a biliary endoprosthesis (stent) to ensure transpapillary drainage [1-4, 9, 22]. The success rate of endoscopic biliary stenting in these patients is high, with low complication rates [1-5, 9, 21, 22].

However, transpapillary biliary access during ERCP fails in about 3-12% of cases, with percutaneous drainage or surgical treatment remaining alternative options [1-7]. At most medical centers, percutaneous transhepatic biliary drainage (PTBD) [17-19] is the treatment of choice after failed transpapillary access during ERCP. The procedure involves percutaneous puncture of the bile ducts and the insertion of a percutaneous drain, with the distal end positioned in the bile duct lumen to allow external bile drainage (Fig. 1) [17-19]. Compared to the endoscopic transpapillary approach, percutaneous biliary drainage is associated with lower efficacy and a higher complication rate [17-19]. The advantage of internal (endoscopic) drainage over external (percutaneous) drainage is primarily related to a lower risk of infection [17-19]. Additionally, external percutaneous drainage, which is often uncomfortable for patients, can pose challenges in long-term management [17-19].

The past few decades have witnessed steady advances in EUS, which facilitates direct, real-time visualization of structures surrounding the gastrointestinal tract [23]. The development of advanced EUS-guided endoscopic techniques has facilitated extra-anatomic transmural access to the biliary tract (across the wall of the upper gastrointestinal tract) [14-16, 19, 20, 24]. With the development of therapeutic applications of EUS, EUS-guided biliary anastomoses have emerged as an alternative to percutaneous transhepatic biliary drainage (PTBD) when ERCP fails have begun to appear in the literature [16, 19, 20, 24-26]. Since the first publications describing EUS-guided transmural biliary access, the method has continued to evolve, resulting in the establishment of several drainage techniques [16, 24].

The European Society of Gastrointestinal Endoscopy (ESGE) 2022 guideline [16] provides detailed recommendations on the therapeutic use of EUS for biliary drainage. More recent guidelines [5, 7] mainly concern the diagnosis of biliary tract strictures, addressing EUS-guided biliary drainage (EUS-BD) only briefly, and without substantially diverging from the ESGE recommendations [16]. Since the publication of the 2022 guidelines [16], subsequent studies have added to the evidence on EUS-BD, potentially warranting an update of the recommendations. This article discusses the role of EUS-BD in biliary endotherapy based on the available literature.

Endoscopic transmural access in biliary endotherapy

The primary indications for endoscopic transmural biliary drainage include [16, 19, 20, 24, 26-30]:

– no possibility of bile duct catheterization during ERCP,

– failure of transpapillary drainage as attempted during ERCP,

– inability to perform ERCP due to altered anatomy within the upper gastrointestinal tract.

The most common indication for transmural drainage is biliary obstruction. Based on the clinical presentation and preprocedural investigations, it is necessary to determine the etiology and location of the biliary stricture, which determine the subsequent endoscopic management [1, 3-5, 9]. In patients with malignant biliary strictures, tumor resectability must be assessed, as this also influences the choice of drainage technique [16, 26-30].

The development of endoscopic transmural drainage techniques has contributed to their increased importance in biliary endotherapy [16]. Initially, endoscopic transmural biliary drainage was considered a palliative treatment for patients with advanced hepatopancreatobiliary malignancies.

The ultimate goal of biliary drainage in patients with unresectable disease is to enhance the comfort and quality of life of patients [21, 22]. More specifically, palliative drainage aims to:

– improve quality of life by relieving symptoms of biliary obstruction, including jaundice and pruritus,

– prevent or treat cholangitis by decompressing the obstructed biliary tree,

– enable further oncological treatment by improving liver function when impaired by biliary obstruction,

– improve digestion by restoring the bile flow into the small intestine, thereby supporting fat and fat-soluble vitamin absorption.

EUS-guided transmural biliary drainage is also increasingly used for preoperative drainage in selected patients with resectable pancreatic head tumors [26-35]. Indications for biliary drainage in cases of resectable pancreaticobiliary tumors [26-35]:

– acute cholangitis,

– planned neoadjuvant treatment,

– delayed surgery,

– severe cholestatic jaundice.

Moreover, the importance of the transmural access is also increasing in biliary endotherapy of benign biliary pathologies [16].

Three different techniques are available for the establishment of transmural access to the bile ducts [16, 26-36]:

– the rendezvous technique,

– the antegrade technique, and

– extra-anatomic transmural anastomoses of bile ducts to the gastrointestinal tract.

The choice of the transmural access approach

The decisive factors in selecting the technique for establishing transmural access to the bile duct include, primarily, the etiology of the stenosis and, in the case of malignant strictures, the resectability of the lesion [26-37]. Endoscopic management of benign biliary strictures is completely different from that of malignant strictures (Fig. 2). In patients with indeterminate strictures during endoscopic procedures, special caution should be exercised when using the transmural biliary approach. In such cases, the same approach is used as for benign stenosis, where transpapillary access is sought using transmural techniques (rendezvous maneuver or antegrade technique) (Fig. 2).

In the case of benign biliary pathologies, transpapillary access should be pursued from the transmural approach using the rendezvous technique [16]. If EUS-guided transpapillary access cannot be established due to the lack of endoscopic access to the major duodenal papilla (or biliary-gastrointestinal anastomosis) as a result of altered anatomy of the upper gastrointestinal tract, intraductal biliary interventions using the antegrade technique remain the treatment of choice [16, 30, 31]. If the rendezvous maneuver is not feasible (due to the inability to pass the guidewire through the biliary tract and the major duodenal papilla into the duodenum), endoscopic transmural anastomosis can be pursued using covered self-expanding stents [16, 26-37].

In malignant biliary strictures, if the rendezvous maneuver is not feasible and transmural biliary stenting cannot be pursued using the antegrade technique, endoscopic biliary-gastrointestinal anastomoses should be established in patients with unresectable lesions, according to the location of the stricture [31-37]. On the other hand, in the case of preoperative drainage of resectable malignant lesions, endoscopic management also depends on the location of the stenosis; however, it should be kept in mind that preoperative endoscopic transmural anastomosis may not be feasible in some patients [26-37]. In patients with distal biliary strictures, most commonly in the setting of resectable pancreatic head tumors, a choledochoduodenostomy can be performed using a transmural lumen-apposing metal stent (LAMS) (Fig. 3) [35]. Bile duct-to-gastrointestinal tract anastomosis should not be pursued in patients with proximal biliary strictures associated with resectable malignancies [16, 30]. In such cases, preoperative percutaneous drainage should be considered [1, 9].

Regardless of the etiology, in both benign and malignant strictures, biliary endotherapy should generally prioritize transmural access to the extrahepatic bile ducts, usually via a transduodenal puncture. If the extrahepatic bile ducts cannot be accessed, most commonly in the case of proximal biliary strictures, can intrahepatic bile duct access be used, usually via a transgastric puncture.

The transmural biliary drainage technique

When transpapillary drainage during ERCP is ineffective or not feasible in patients with obstructive jaundice, most commonly due to biliary stenosis, a transmural puncture of the bile ducts is usually performed under EUS guidance during the same endoscopic procedure after replacing the duodenoscope with a linear echoendoscope [16, 26-38]. After a needle is placed within the lumen of the dilated bile ducts under EUS guidance, the stylet is removed from the needle lumen, and the contents are aspirated therethrough; the presence of biliary contents within the syringe confirms the correct positioning of the needle tip [31]. Next, contrast agent is administered through the needle, and retrograde cholangiography is performed [31, 36]. During cholangiopancreatography, the level of biliary stenosis is determined, and a decision is made on further management [16, 31, 36]. The needle is flushed with saline, and a guidewire is inserted through the needle into the bile duct. If the guidewire can be successfully guided through the bile duct and across the papilla into the duodenal lumen, the drainage can be performed using the rendezvous or antegrade techniques [16]. If the guidewire cannot be passed through the bile duct and across the major duodenal papilla into the duodenal lumen, an extra-anatomic transmural biliary-enteric anastomosis can be created [26-38].

The rendezvous technique

Endoscopic procedures using the rendezvous technique involve a transmural puncture of the biliary tract and a guidewire being passed through the bile ducts and across the major duodenal papilla into the duodenal lumen under EUS guidance [16, 30, 31]. The guidewire is then left in place, with its transpapillary end in the duodenal lumen and the transmural end in the stomach, while the central segment of the guidewire remains within the biliary tract [16, 30, 31, 36, 38]. Once the guidewire is left in the gastrointestinal tract lumen, the linear echoendoscope is replaced by a duodenoscope, and ERCP is performed from the transpapillary access after the guidewire is grasped within the duodenum [16, 38]. The advantage of this transmural technique consists in that endoscopic biliary procedures can be continued via the natural transpapillary route [16, 30, 38].

The antegrade technique

An alternative to the EUS-guided rendezvous technique is to perform intraductal interventions via the antegrade route through transmural access [16, 36, 38]. This approach is particularly relevant when the anatomy of the upper gastrointestinal tract has been altered by previous surgery. As in the rendezvous technique, the antegrade technique involves inserting a guidewire through the bile duct and across the major duodenal papilla (or, in some cases, across a biliary-enteric anastomosis) into the intestinal lumen. However, because of these anatomical alterations, it may be impossible to gain access to the bowel after switching from an echoendoscope to a duodenoscope. In such cases, antegrade intraductal interventions through transmural access or antegrade stent placement across the papilla are the treatment of choice [16, 30, 31, 36, 38].

However, in many patients, the guidewire cannot be inserted from a transmural access along the biliary tract and across the major duodenal papilla into the duodenal lumen. In such cases, the rendezvous or antegrade techniques cannot be pursued, and extra-anatomic transmural biliary drainage may be required [16, 26-38].

Extra-anatomic transmural biliary anastomoses

There are four types of anastomoses between the biliary tract and the gastrointestinal lumen [16, 26-38]:

• anastomoses involving intrahepatic bile ducts:

– endoscopic hepaticoesophagostomy,

– endoscopic hepaticogastrostomy;

• anastomoses involving extrahepatic bile ducts:

– endoscopic choledochoduodenostomy,

– endoscopic cholecystoduodenostomy.

In the absence of transpapillary access to the duodenum following a transmural puncture of the bile duct, the puncture tract can be dilated to create an anastomosis between the biliary tract and the gastrointestinal lumen, with placement of a transmural stent to provide extra-anatomic biliary drainage [16]. EUS-guided endoscopic transmural biliary drainage facilitates transesophageal (endoscopic hepaticoesophagostomy) or transgastric (endoscopic hepaticogastrostomy) access to intrahepatic bile ducts or transduodenal access to extrahepatic bile ducts (endoscopic choledochoduodenostomy or endoscopic cholecystoduodenostomy) [26-37].

According to the literature, transduodenal access via endoscopic choledochoduodenostomy is generally preferred, as it is closest to the transpapillary route and provides physiological bile drainage into the duodenum [16, 26-36]. However, in some cases, when duodenal access cannot be established due to the altered anatomy of the upper gastrointestinal tract or tumor infiltration obstructing the duodenal lumen, transgastric access to the intrahepatic bile ducts via endoscopic hepaticogastrostomy may be preferred [39, 40].

Compared to the traditional percutaneous transhepatic biliary drainage, EUS-guided transmural biliary-enteric anastomoses have reported technical and clinical success rates exceeding 90%, while some studies report higher complication rates with external percutaneous drainage [17-20, 25, 26]. A systematic review and meta-analysis of nine studies found no difference in technical success rates between endoscopic extra-anatomic biliary anastomoses and external percutaneous drainage in patients after failed ERCP [20]. However, clinical success rates were higher and complication and reintervention rates were lower with EUS-guided transmural biliary anastomosis than with percutaneous drainage [20]. In addition to avoiding the discomfort associated with external drains in palliative care, internal drainage may reduce infection-related reinterventions and hospitalizations [17-20].

Studies of EUS-guided extra-anatomic biliary anastomoses have reported high technical success rates (90-94.7%) and clinical success rates (87-94%) along with acceptable complication rates (16-29%) [26-36]. Comparisons of extrahepatic biliary access by choledochoduodenostomy or cholecystoduodenostomy with intrahepatic access by hepaticogastrostomy have found similar rates of technical success and clinical success, although some studies have reported higher complication rates with intrahepatic access [26-36, 39, 40]. Other studies have found no significant differences in efficacy or safety between endoscopic hepaticogastrostomy and endoscopic choledochoduodenostomy/cholecystoduodenostomy [26-36, 39, 40].

Extra-anatomic anastomoses of extrahepatic bile ducts

As mentioned above, literature reports point to transduodenal access by means of endoscopic choledochoduodenostomy as the most preferred route for the establishment of biliary-gastrointestinal anastomosis facilitating the most physiological drainage of bile into the duodenum [27-32]. Endoscopic choledochoduodenostomy is pursued in patients with distal biliary stenosis [27-32]. In some cases, the anastomosis is established just above the major duodenal papilla by what appears to be an endoscopic suprapapillary fistulotomy performed under EUS guidance. Nevertheless, free access to the duodenum, if only to the duodenal bulb, is a prerequisite for endoscopic choledochoduodenostomy. Following the transmural/transduodenal puncture of the dilated common bile duct, the tract is dilated to create a transmural anastomosis, and a fully or partially coated self-expandable biliary stent (40-80 mm long) is placed (Fig. 4A-H).

A completely different approach to EUS-guided endoscopic choledochoduodenostomy consists in using an electrocautery-enhanced LAMS insertion kit, which ensures that the procedure is safely performed in four consecutive steps without the need to use any other tools described hereinabove [35]. The transmural LAMS to be delivered using the kit should be 8 mm in length and 6-8 mm in diameter after expansion. The use of LAMS endoprostheses in choledochoduodenostomy procedures is possible in both benign and malignant biliary strictures and provides an alternative to self-expanding, fully or partially coated transmural biliary stents [31, 34-36]. LAMS placement has been recommended for preoperative biliary drainage in patients with resectable pancreatic tumors causing distal bile duct obstruction [35]. In these cases, transmural anastomosis should be established at a possibly most distal location within the dilated common bile duct, just above the biliary stricture, which is of great importance from the standpoint of future tumor resection surgery [35].

Endoscopic cholecystoduodenostomy is generally a less-preferred rescue option for biliary drainage [41, 42]. It may be considered when endoscopic choledochoduodenostomy and endoscopic intrahepatic bile duct anastomosis have failed or are not feasible [31, 36, 41, 42].

Extra-anatomic anastomoses of intrahepatic bile ducts

Within the group of extra-anatomic anastomoses of the intrahepatic bile ducts to the upper gastrointestinal tract, the two types as distinguished on the basis of the transmural access location: biliary-esophageal anastomoses (endoscopic hepaticoesophagostomy) [36, 43] and biliogastric anastomoses (endoscopic hepaticogastrostomy) [16, 39, 40]. In the absence of access to the extrahepatic bile ducts, which is generally preferred for extra-anatomic transmural biliary drainage, intrahepatic access can be performed [39, 40]. Transgastric access by means of endoscopic hepaticogastrostomy is the standard method of establishing access to intrahepatic bile ducts [16, 39, 40]. However, in some cases where the intrahepatic bile ducts cannot be accessed from the stomach, especially in cases of advanced tumors associated with hypertrophy of the left lobe of the liver, endoscopic anastomosis of intrahepatic bile ducts to the esophagus (endoscopic hepaticoesophagostomy) can be performed [43].

For both transgastric and transesophageal access to intrahepatic bile ducts, after the transmural puncture tract is widened and the anastomosis is established between the biliary and gastrointestinal tracts, a special partially covered self-expanding endoprosthesis is placed across the transmural tract such that the uncoated half of the endoprosthesis is left within the intrahepatic bile ducts and the coated half spans the anastomotic segment between the hepatic parenchyma and the lumen of the gastrointestinal tract (Fig. 5A-L) [16, 36, 39, 40, 43].

Transmural intrahepatic bile duct anastomosis is indicated in patients with unresectable tumors causing proximal malignant biliary strictures [16, 39, 40, 43]. In patients with resectable proximal biliary strictures who are selected for preoperative biliary drainage, percutaneous biliary drainage is indicated, since transmural gastric drainage of intrahepatic bile ducts is contraindicated in patients with resectable tumors [16].

Complications related to transmural access

Complications related to the transmural access in biliary endotherapy mainly involve the extra-anatomic anastomoses between the biliary tract and the gastrointestinal tract [26-36, 38]. The overall adverse event rate related to EUS-BD ranges from 7% to 20% [26-36, 38].

In fact, complications of endoscopic transmural approach can be divided into two main groups related to bleeding or hemorrhage as well as stent misdeployment or stent dysfunction in form of migration, stent obstruction and cholangitis, bile leakage with biliary peritonitis or perforation of gastrointestinal tract (Table 1) [26-36, 38].

As with any surgical anastomosis, the two main groups of early complications (occurring within 7 days after surgery) are anastomotic leaks and bleedings from the anastomotic area. Late complications, on the other hand, usually involve the obstruction of the endoscopic biliary anastomosis.

In the case of early complications, the type of endoscopic anastomosis performed is decisive for further therapeutic management [38]. While endotherapy using various endoscopic hemostasis methods is the mainstay of treatment in the case of bleeding from both intrahepatic and extrahepatic duct anastomoses, the role of endotherapy is limited in the case of anastomotic leaks, for which surgical techniques are used more frequently [36].

In the case of bleeding following transmural endoscopy, it is extremely important to obtain contrast-enhanced computed tomography (CECT) with angiography, especially in the case of intrahepatic bile duct anastomoses to the gastrointestinal tract, to exclude damage to large blood vessels, which is much more often the case precisely in patients after endoscopic hepaticogastrostomy. When major vascular injury is identified, endoscopic hemostasis methods are ineffective, and surgical or endovascular intervention using interventional radiology or vascular surgery techniques is usually required [31, 36].

Early anastomotic leak is most commonly associated with partial or complete migration of the endoprosthesis across the anastomosis wall, resulting in bile leaking into the peritoneal cavity and possibly leading to bile peritonitis [36, 38]. In the case of partial migration of the stent, endoscopic intervention is possible, usually involving transmural placement of another endoprosthesis, usually in a stent-in-stent fashion to stop bile leakage by sealing the anastomosis [38]. In most patients, the above approach is sufficient, and no other interventions are required apart from a prolonged course of intravenous antibiotics.

The management of complete migration of a transmural stent in the early postoperative period (up to 7 days after surgery) is completely different [31, 36, 38, 39]. In these patients, diffuse biliary peritonitis commonly develops because of bile leakage from the site of stent displacement, along with symptoms of gastrointestinal perforation caused by migration of the stent from the anastomotic site in the gastrointestinal wall. In the case of complete migration of a transmural biliary endoprosthesis, management usually involves laparotomy, as endoscopic treatment of this type of complications is often ineffective or impossible.

The surgical approach to complete stent displacement depends on the type of endoscopic biliary anastomosis that had been established [31, 36]. In the case of endoscopic choledochoduodenostomy, surgical management usually consists in suturing the perforation within the duodenum and draining the bile duct using Kehr’s T-tube. Surgical management of stent displacement after endoscopic hepaticogastrostomy is much more challenging. Every effort should be made to keep the biliary end of the transmural endoprosthesis within the intrahepatic bile ducts, as surgical reconstruction of the anastomotic opening within the liver parenchyma is usually impossible. For this reason, even in cases of complete stent displacement, intraoperative repositioning of the stent is recommended, followed by the sealing of the anastomotic leak using a patch made of the greater omentum or a plastic material, which seems to be the optimum approach. Adequate peritoneal lavage and drainage are also important because of the associated biliary peritonitis.

Late complications associated with transmural biliary access usually manifest as symptoms of cholangitis secondary to stent obstruction due to the endoprosthesis lumen being overgrown with tumor tissue or obstructed with biliary sludge or digestive contents, impeding or preventing the outflow of bile from the biliary tract [36, 38]. In all cases of biliary anastomotic obstruction, efforts should be made to restore the outflow of bile into the gastrointestinal tract, most frequently by restoring stent patency using endoscopic techniques [38].

One of the late complications is delayed bleeding caused by LAMS friction against the contralateral bile duct wall. Placement of a coaxial double-pigtail plastic stent through the metal stent may reduce this risk by pushing the duct wall away from the distal flange of the metal stent [38].

Clinical conclusions (and a management algorithm)

Endoscopic transmural access has expanded the options for endoscopic treatment of biliary disease, especially biliary strictures [26-36]. A growing number of literature reports suggest that compared to ERCP, extra-anatomic biliary drainage may reduce the risk of postprocedural acute pancreatitis and improve surgical outcomes in patients with operable biliary strictures [33-35, 44].

Despite these promising findings on the efficacy and safety of transmural access in biliary endotherapy reported in the literature and discussed in this paper, anatomical transpapillary access, as established in the course of ERCP, remains the primary biliary drainage route. EUS-guided extra-anatomic transmural access is reserved for cases in which ERCP has failed or was deemed impossible due to the altered anatomy of the upper gastrointestinal tract. In the case of ERCP failure, the rendezvous technique should be considered to achieve transpapillary access, regardless of the etiology of the pathology within the biliary tract. If the rendezvous maneuver is ineffective or not feasible, extra-anatomic anastomoses between the biliary tract and the gastrointestinal tract may be established, particularly in patients with malignant strictures.

In patients with benign biliary strictures, surgery to restore normal bile flow remains an established treatment option. EUS-BD should be considered a bridge to surgery or an alternative for patients who are not candidates for surgical intervention as well as for patients who do not consent to surgical treatment.

Further prospects for the development of the method

It seems that in the near future, transmural drainage by endoscopic choledochoduodenostomy may have a role as an alternative to ERCP with biliary stenting for preoperative drainage in patients with resectable pancreatic head tumors causing biliary strictures.

Another promising development is the use of fully coated and removable transmural endoprostheses for hepaticogastrostomy. In patients with benign biliary strictures and altered upper gastrointestinal tract anatomy that prevents conventional ERCP, endoscopic hepaticogastrostomy may facilitate intraductal interventions being performed by the antegrade route, with subsequent removal of transmural endoprosthesis at the end of the treatment. Thus, transmural access may evolve beyond biliary drainage to provide a route for advanced EUS-guided interventions within the biliary tract.

Summary

The continuous development of advanced endoscopic hepatopancreatobiliary techniques has facilitated transmural access being used in biliary endotherapy, expanding treatment outcomes. Both the experience of the treating center and the assessment of the risk of complications, which is frequently related to anatomical conditions and the extent of malignancy, are important when choosing the type and technique of extra-anatomical endoscopic transmural biliary drainage. EUS-guided extra-anatomic transmural biliary access expands endotherapeutic options and may reduce the need for other interventional techniques.

Disclosures

This research received no external funding.

Institutional review board statement: Not applicable.

The authors declare no conflict of interest.

References

  1. Nakai Y, Isayama H, Wang HP, et al. International consensus statements for endoscopic management of distal biliary stricture. J Gastroenterol Hepatol 2020; 35: 967-979.
  2. Dorrell R, Pawa S, Pawa R. Endoscopic management of malignant biliary stricture. Diagnostics (Basel) 2020; 10: 390.
  3. ASGE guidelines for clinical application. The role of ERCP in diseases of the biliary tract and pancreas. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1999; 50: 915-920.
  4. Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017. Endoscopy 2018; 50: 910-930.
  5. Gadour E, Crinò SF, Spadaccini M, Facciorusso A. Diagnostic and therapeutic strategies for biliary strictures: a comparison of ACG, ESGE, and ASGE guidelines. Expert Rev Gastroenterol Hepatol 2026; 20: 11-16.
  6. Singh A, Gelrud A, Agarwal B. Biliary strictures: Diagnostic considerations and approach. Gastroenterol Rep 2014; 3: 22-31.
  7. Facciorusso A, Crinò SF, Gkolfakis P, et al. Diagnostic work-up of bile duct strictures: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2025; 57: 166-185. Erratum in: Endoscopy 2025; 57: C17.
  8. American Society for Gastrointestinal Endoscopy Standards of Practice Committee. Anderson MA, Appalaneni V, Ben-Menachem T, et al. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. Gastrointest Endosc 2013; 77: 167-174.
  9. Roque J, Ho SH, Goh KL. Preoperative drainage for malignant biliary strictures: Is it time for self-expanding metallic stents? Clin Endosc 2015; 48: 8-14.
  10. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-1261.
  11. Bertuccio P, Bosetti C, Levi F, et al. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Ann Oncol 2013; 24: 1667-1674.
  12. Tyson GL, Ilyas JA, Duan Z, et al. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci 2014; 59: 3103-3110.
  13. Ballinger AB, McHugh M, Catnach SM, et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994; 35: 467-470.
  14. Giovannini M, Moutardier V, Pesenti C, et al. Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy 2001; 33: 898-900.
  15. Burmester E, Niehaus J, Leineweber T, et al. EUS-cholangio-drainage of the bile duct: Report of 4 cases. Gastrointest Endosc 2003; 57: 246-251.
  16. van der Merwe SW, van Wanrooij RLJ, Bronswijk M, et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54: 185-205.
  17. Pinchuk L, Magnanini F, Nardi G, et al. Percutaneous transhepatic biliary drainage in obstructive jaundice. Acta Gastroenterol Latinoam 1981; 11: 279-284.
  18. Winick AB, Waybill PN, Venbrux AC. Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol 2001; 4: 200-206.
  19. Lee TH, Choi JH, Park do H, et al. Similar efficacies of endoscopic ultrasound-guided transmural and percutaneous drainage for malignant distal biliary obstruction. Clin Gastroenterol Hepatol 2016; 14: 1011-1019.e3.
  20. Sharaiha RZ, Khan MA, Kamal F, et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc 2017; 85: 904-914.
  21. Manegold BC. Obstructive jaundice of benign and malignant origin: Endoscopy in diagnosis and therapy. Langenbecks Arch Chir 1981; 355: 263-271.
  22. Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev 2006; 1: CD004200.pub2.
  23. Khashab MA, Varadarajulu S. Endoscopic ultrasonography as a therapeutic modality. Curr Opin Gastroenterol 2012; 28: 467-476.
  24. Giovannini M, Bories E. EUS-guided biliary drainage. Gastroenterol Res Pract 2012; 2012: 348719.
  25. Gupta K, Mallery S, Hunter D, et al. Endoscopic ultrasound and percutaneous access for endoscopic biliary and pancreatic drainage after initially failed ERCP. Rev Gastroenterol Disord 2007; 7: 22-37.
  26. Baniya R, Upadhaya S, Madala S, et al. Endoscopic ultrasound-guided biliary drainage versus percutaneous transhepatic biliary drainage after failed endoscopic retrograde cholangiopancreatography: a meta-analysis. Clin Exp Gastroenterol 2017; 10: 67-74.
  27. Khan MA, Akbar A, Baron TH, et al. Endoscopic ultrasound-guided biliary drainage: a systematic review and meta-analysis. Dig Dis Sci 2016; 61: 684-703.
  28. Chavalitdhamrong D, Draganov PV. Endoscopic ultrasound-guided biliary drainage. World J Gastroenterol 2012; 18: 491-497.
  29. Wang K, Zhu J, Xing L, et al. Assessment of efficacy and safety of EUS-guided biliary drainage: a systematic review. Gastrointest Endosc 2016; 83: 1218-1227.
  30. Mukai S, Itoi T. Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice. Expert Rev Gastroenterol Hepatol 2023; 17: 1197-1204.
  31. Jagielski M, Zieliński M, Piątkowski J, et al. The role of endoscopic ultrasound-guided transmural approach in the management of biliary obstructions. Surg Laparosc Endosc Percutan Tech 2022; 32: 285-291.
  32. Canakis A, Tyberg A. Endoscopic ultrasound-guided biliary drainage (EUS-BD). Gastrointest Endosc Clin N Am 2024; 34: 487-500.
  33. Khoury T, Sbeit W, Fumex F, et al. Endoscopic ultrasound- versus ERCP-guided primary drainage of inoperable malignant distal biliary obstruction: systematic review and meta-analysis of randomized controlled trials. Endoscopy 2024; 56: 955-963.
  34. Teoh AYB, Napoleon B, Kunda R, et al. EUS-Guided choledocho-duodenostomy using lumen apposing stent versus ERCP with covered metallic stents in patients with unresectable malignant distal biliary obstruction: a multicenter randomized controlled trial (DRA-MBO Trial). Gastroenterology 2023; 165: 473-482.e2.
  35. Tyberg A, Sarkar A, Shahid HM, et al. EUS-guided biliary drainage versus ERCP in malignant biliary obstruction before hepatobiliary surgery: an international multicenter comparative study. J Clin Gastroenterol 2023; 57: 962-966.
  36. Zieliński M, Jagielski M, Piątkowski J, et al. Safety and effectiveness of consecutive 191 endoscopic ultrasonography-guided biliary drainage procedures: a single-center experience. Pol Przegl Chir 2024; 96: 31-38.
  37. Nabi Z, Samanta J, Dhar J, et al. Comparative effectiveness of ERCP and EUS-guided techniques for “primary biliary drainage” in malignant distal biliary obstruction: a systematic review and meta-analysis. J Clin Gastroenterol 2025; 59: 801-808.
  38. van Wanrooij RLJ, Bronswijk M, Kunda R, et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) technical review. Endoscopy 2022; 54: 310-332.
  39. Jagielski M, Zieliński M, Piątkowski J, et al. Outcomes and limitations of endoscopic ultrasound-guided hepaticogastrostomy in malignant biliary obstruction. BMC Gastroenterol 2021; 21: 202.
  40. Uemura RS, Khan MA, Otoch JP, et al. EUS-guided choledochoduodenostomy versus hepaticogastrostomy: a systematic review and meta-analysis. J Clin Gastroenterol 2018; 52: 123-130.
  41. Rizzo GEM, Crinò SF, Vanella G, et al. EUS-guided gallbladder drainage as a rescue in distal malignant biliary obstruction: A systematic review with meta-analysis. Endosc Ultrasound 2025; 14: 41-47.
  42. Hemerly MC, de Moura DTH, do Monte Junior ES, et al. Endoscopic ultrasound (EUS)-guided cholecystostomy versus percutaneous cholecystostomy (PTC) in the management of acute cholecystitis in patients unfit for surgery: a systematic review and meta-analysis. Surg Endosc 2023; 37: 2421-2438.
  43. Rugivarodom M, Aswakul P, Techathuvanan K, et al. Efficacy and safety of EUS-guided hepaticoesophagostomy (EUS-HES) for malignant biliary obstruction: the first case series. Surg Endosc 2022; 36: 1117-1122.
  44. Barbosa EC, Santo PADE, Baraldo S, et al. EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: a systematic review and meta-analysis of randomized controlled trials. Gastrointest Endosc 2024; 100: 395-405.e8.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Share
without publication fees